Splicing abnormalities caused by a novel mutation in the PHKA2 gene in children with glycogen storage disease type IX / 中华肝脏病杂志

Objective: Glycogen storage disease type IX (GSD-IX) is a rare primary glucose metabolism abnormality caused by phosphorylase kinase deficiency and a series of pathogenic gene mutations. The clinical characteristics, gene analysis, and functional verification of a mutation in a child with hepatomegaly are summarized here to clarify the pathogenic cause of the disease. Methods: The clinical data of a child with GSD-IX was collected. Peripheral blood from the child and his parents was collected for genomic DNA extraction. The patient's gene diagnosis was performed by second-generation sequencing. The suspected mutations were verified by Sanger sequencing and bioinformatics analysis. The suspected splicing mutations were verified in vivo by RT-PCR and first-generation sequencing. Results: Hepatomegaly, transaminitis, and hypertriglyceridemia were present in children. Liver biopsy pathological examination results indicated glycogen storage disease. Gene sequencing revealed that the child had a c.285 + 2_285 + 5delTAGG hemizygous mutation in the PHKA2 gene. Sanger sequencing verification showed that the mother of the child was heterozygous and the father of the child was of the wild type. Software such as HSF3.1 and ESEfinder predicted that the gene mutation affected splicing. RT-PCR of peripheral blood from children and his mother confirmed that the mutation had caused the skipping of exon 3 during the constitutive splicing of the PHKA2 gene. Conclusion: The hemizygous mutation in the PHKA2 gene (c.285 + 2_285 + 5delTAGG) is the pathogenic cause of the patient's disease. The detection of the novel mutation site enriches the mutation spectrum of the PHKA2 gene and serves as a basis for the family's genetic counseling.

Glucogenosis hepática: a propósito de un caso / Hepatic glycogenosis: a case report

RESUMEN Las glucogenosis abarcan un rango de enfermedades que se caracterizan por el almacenamiento o utilización anormal del glucógeno, siendo los órganos más afectados el músculo y/o el hígado. La hepatomegalia puede ser un signo clínico que guie al diagnóstico. Describimos a un paciente de 15 años de edad con hepatomegalia, hipertransaminasemia y retraso del crecimiento, a quien se le diagnosticó glucogenosis por biopsia hepática.

ABSTRACT The glycogen storage diseases contain a range of diseases that are characterized by the abnormal storage or utilization of glycogen, the organs most affected being muscle and / or liver. Hepatomegaly may be a clinical sign that could guide to the diagnosis. We describe a 15-year-old patient with hepatomegaly, hypertransaminasemia and growth retardation. He was diagnosed with a glycogen storage disease by liver biopsy.

Development of Hepatocellular Carcinoma in Patients with Glycogen Storage Disease: a Single Center Retrospective Study

Glycogen storage disease IXa in a 9-year-old Filipino boy with short stature: A case report

@#Glycogen storage disease (GSD) type IXa, due to a deficiency of hepatic phosphorylase b kinase, results in liver enlargement, growth retardation and fasting ketosis. Many are asymptomatic and do not require treatment. This is the first documented GSD IXa in a Filipino boy evaluated for short stature.

A Case of Glycogen Storage Disease IV with Rare Homozygous Mutations in the Glycogen Branching Enzyme Gene / 대한소아소화기영양학회지

Glycogen storage disease (GSD) IV is a rare autosomal recessive inherited disorder caused by mutations in the gene coding for glycogen branching enzyme leading to progressive liver disease. GSD IV is associated with mutations in GBE1, which encodes the glycogen branching enzyme. We report a case of GSD IV with rare homozygous mutations in the GBE1 gene (c.791G>A (p.Gly264Glu), which was successfully treated by liver transplantation.

Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib

BACKGROUND: Molecular techniques are fundamental for establishing an accurate diagnosis and therapeutic approach of glycogen storage diseases (GSDs). We aimed to evaluate SLC37A4 mutation spectrum in Korean GSD Ib patients. METHODS: Nine Korean patients from eight unrelated families with GSD Ib were included. SLC37A4 mutations were detected in all patients with direct sequencing using a PCR method and/or whole-exome sequencing. A comprehensive review of previously reported SLC37A4 mutations was also conducted. RESULTS: Nine different pathogenic SLC37A4 mutations were identified in the nine patients with GSD Ib. Among them, four novel mutations were identified: c.148G>A (pGly50Arg), c.320G>A (p.Trp107*), c.412T>C (p.Trp138Arg), and c.818G>A (p.Gly273Asp). The most common mutation type was missense mutations (66.7%, 6/9), followed by nonsense mutations (22.2%, 2/9) and small deletion mutations (11.1%, 1/9). The most common mutation identified in the Korean population was c.443C>T (p.Ala148Val), which comprised 39.9% (7/18) of all tested alleles. This mutation has not been reported in GSD Ib patients in other ethnic populations. CONCLUSIONS: This study expands knowledge of the SLC37A4 mutation spectrum in Korean patients with GSD Ib.

Epstein-Barr Virus Infection associated Transverse Myelitis with Brain Involvement in an Immunosuppressed Patient: A Case Report

A 19-year-old girl with immunosuppressive agents of tacrolimus and mychophenolate mofetil following liver transplantation due to glycogen storage disease visited hospital due to lower extremity motor weakness and blurred vision. Motor power was checked as grade II in the upper extremities and grade 0 in the lower extremities with absence of deep tendon reflexes and anal sphincter dysfunction. The magnetic resonance imaging (MRI) showed increased T2 high signal intensity lesions from C4 to L2 level of spinal cord, cerebral cortex, and the left optic nerve. The cerebrospinal fluid (CSF) analysis showed pleocytosis. Epstein-Barr virus (EBV) deoxyribonucleic acid (DNA) was detected as 5,954 copies/mL in CSF whereas all other microbiologic tests were negative. Anti-aquaporin 4 antibody and oligoclonal band were not detected. Intravenous immunoglobulin, methylprednisolone pulse therapy and 3-week course of acyclovir were administered. Although motor power in the upper extremities recovered to grade V, motor power in the lower extremities did not show any improvement. The EBV viral load was not detected in the follow-up CSF examination. EBV infection in an immune-compromised patient could cause extensive demyelinating diseases in central nervous system and result in severe disability.

A Novel Homozygous LIPA Mutation in a Korean Child with Lysosomal Acid Lipase Deficiency / 대한소아소화기영양학회지

Patients with lysosomal acid lipase (LAL) deficiency and glycogen storage disease (GSD) demonstrated hepatomegaly and dyslipidemia. In our case, a 6-year-old boy presented with hepatosplenomegaly. At 3 years of age, GSD had been diagnosed by liver biopsy at another hospital. He showed elevated serum liver enzymes and dyslipidemia. Liver biopsy revealed diffuse microvesicular fatty changes in hepatocytes, septal fibrosis and foamy macrophages. Ultrastructural examination demonstrated numerous lysosomes that contained lipid material and intracytoplasmic cholesterol clefts. A dried blood spot test revealed markedly decreased activity of LAL. LIPA gene sequencing identified the presence of a novel homozygous mutation (p.Thr177Ile). The patient's elevated liver enzymes and dyslipidemia improved with enzyme replacement therapy. This is the first report of a Korean child with LAL deficiency, and our findings suggest that this condition should be considered in the differential diagnosis of children with hepatosplenomegaly and dyslipidemia.

A Novel Homozygous LIPA Mutation in a Korean Child with Lysosomal Acid Lipase Deficiency / 대한소아소화기영양학회지

Patients with lysosomal acid lipase (LAL) deficiency and glycogen storage disease (GSD) demonstrated hepatomegaly and dyslipidemia. In our case, a 6-year-old boy presented with hepatosplenomegaly. At 3 years of age, GSD had been diagnosed by liver biopsy at another hospital. He showed elevated serum liver enzymes and dyslipidemia. Liver biopsy revealed diffuse microvesicular fatty changes in hepatocytes, septal fibrosis and foamy macrophages. Ultrastructural examination demonstrated numerous lysosomes that contained lipid material and intracytoplasmic cholesterol clefts. A dried blood spot test revealed markedly decreased activity of LAL. LIPA gene sequencing identified the presence of a novel homozygous mutation (p.Thr177Ile). The patient's elevated liver enzymes and dyslipidemia improved with enzyme replacement therapy. This is the first report of a Korean child with LAL deficiency, and our findings suggest that this condition should be considered in the differential diagnosis of children with hepatosplenomegaly and dyslipidemia.

Quando a preguiça é sinônimo de doença - um caso de doença de McArdle / When laziness unveils the disease - a case of McArdle disease / Cuando la pereza es sinónimo de enfermedad - un caso de enfermedad de McArdle

A doença de McArdle é uma doença rara, autossômica recessiva, manifestando-se com intolerância ao exercício, mialgias e crises de mioglobinúria por rabdomiólise. Pode complicar-se com insuficiência renal e isquemia muscular associada a anestésicos inalados e relaxantes musculares. Relata-se um caso clínico de um homem de 38 anos que apresentava queixas repetidas de cansaço, palpitações e "sensação de que o músculo bloqueava e encolhia" (sic) durante o exercício, obrigando-o a parar para recuperar. Este quadro estava presente desde a adolescência e cessava com redução do exercício. Foi avaliado, apresentando uma CPK de 554mcg/L, sem outras alterações, pelo que foi referenciado pela médica de família para consulta em Neurologia. Nesta foi solicitada uma biópsia muscular, que revelou doença de McArdle. O médico de família deve ser capaz gerir os casos que se apresentam inespecificamente, valorizando queixas específicas e persistentes no tempo, estando alerta para as situações que possam sugerir uma doença incomum.

McArdle's disease is a rare, autosomal recessive disease, manifesting through exercise intolerance, myalgia and myoglobinuria crises by rhabdomyolysis. Renal failure and muscular ischemia associated with inhaled anesthetics and muscle relaxants may occur. This is a case of a 38-year-old man who presented repeated complaints of fatigue, palpitations and "feeling that the muscle blocked up and shrunk" (sic) during exercise, forcing him to stop. These complaints occurred since adolescence and ceased with exercise reduction. The patient was evaluated and had a CPK of 554mcg/L, without other alterations in the exams, thus being referred to a Neurology appointment by his family doctor. He then was submitted to a muscular biopsy which later revealed McArdle's disease. The family doctor should be able to manage cases that arise nonspecifically, valuing specific and persistent complaints over time and remain alert for situations that suggest an uncommon disease

La enfermedad de McArdle es una enfermedad rara, autosómica recessiva, manifestándose como intolerancia al ejercicio, mialgias y crisis de mioglobinuria por rabdomiolisis. Puede complicarse con insuficiencia renal e isquemia muscular asociada con anestésicos inhalatorios y relajantes musculares. Presentamos un caso de un hombre de 38 años que había repetidas quejas de fatiga, palpitaciones y "sensación de músculo bloqueado y encogido" (sic) durante el ejercicio físico, lo que le obligó a parar para recuperarse. Este marco estaba presente desde la adolescencia y desaparecía con el cese de ejercicio. El paciente fue evaluado y mediante la presentación de una CPK de 554mcg/L, sin otras alteraciones, se hace referencia a la consulta de Neurologia. En esta se ha hecho una biopsia de músculo que reveló la enfermedad de McArdle. El médico de familia debe ser capaz de manejar los casos que se presentan de manera inespecífica, dando importância a las quejas específicas y persistentes en el tiempo y estar alerta para situaciones que podrían sugerir una enfermedad poco frecuente.

Perfil clínico-epidemiológico de pacientes con sospecha diagnóstica de glucogenosis hepática de 1 a 18 años en el Hospital Nacional de Niños Benjamín Bloom en el período 2005 a 2015 / Clinical-epidemiological profile of patients with suspected diagnosis of hepatic glycogenosis aged 1 to 18 years at the Benjamín Bloom National Children's Hospital in the period 2005 to 2015

Las glucogenosis son alteraciones del metabolismo del glucógeno caracterizados por la existencia de depósitos cuantitativa o cualitativamente anormales de este polisacárido en el organismo. La hipoglicemia es el hecho característico y que define muchas veces per se la enfermedad. El objetivo es describir los signos, síntomas, hallazgos de laboratorio y gabinete que presentaron los pacientes, y que orientaron al especialista al diagnóstico de una enfermedad de depósito del glucógeno. Se realizó un estudio transversal, retrospectivo y descriptivo. La población fue de 20 pacientes obtenidos de los registros de la consulta externa de Gastroenterología con primer diagnóstico de Enfermedades de depósito de glucógeno, utilizando el instrumento de recolección. Las tablas y gráficos se realizaron utilizando el programa Microsoft Excel. La edad promedio al momento del diagnóstico fue de 4.55+/-2.60, siendo más frecuente las edades de 6 a 10 años con 9 pacientes (45%). De los 20 pacientes, 15 (75%) fueron del género masculino teniendo una relación M/F de 3:1. En los resultados de laboratorio se encontró en 17 (85%) alteraciones de transaminasas y, en los de gabinete, a 20 (100%) se les realizó ultrasonografía abdominal con hepatomegalia como hallazgo más frecuente. Se le practicó biopsia hepática a 17 (85%) pacientes y el hallazgo más encontrado fue el aumento del depósito de glucógeno. Conclusiones: En los pacientes se observa predominio del sexo masculino. El signo clínico que ha presentado la mayoría ha sido la hepatomegalia con distensión abdominal y el que inició el estudio de estos pacientes. La ultrasonografía fue el único estudio de gabinete utilizado. La biopsia hepática contribuyó al diagnóstico al describir depósitos de glucógeno como hallazgo

Esophageal Stricture Secondary to Candidiasis in a Child with Glycogen Storage Disease 1b / 대한소아소화기영양학회지

Esophageal candidiasis is commonly seen in immunocompromised patients; however, candida esophagitis induced stricture is a very rare complication. We report the first case of esophageal stricture secondary to candidiasis in a glycogen storage disease (GSD) 1b child. The patient was diagnosed with GSD type 1b by liver biopsy. No mutation was found in the G6PC gene, but SLC37A4 gene sequencing revealed a compound heterozygous mutation (p.R28H and p.W107X, which was a novel mutation). The patient's absolute neutrophil count was continuously under 1,000/µL when he was over 6 years of age. He was admitted frequently for recurrent fever and infection, and frequently received intravenous antibiotics, antifungal agents. He complained of persistent dysphagia beginning at age 7 years. Esophageal stricture and multiple whitish patches were observed by endoscopy and endoscopic biopsy revealed numerous fungal hyphae consistent with candida esophagitis. He received esophageal balloon dilatation four times, and his symptoms improved.

Recurrent Episodes of Rhabdomyolysis after Seizures in a Patient with Glycogen Storage Disease Type V

No abstract available.

Clinical, Biochemical, and Genetic Characterization of Glycogen Storage Type IX in a Child with Asymptomatic Hepatomegaly / 대한소아소화기영양학회지

Glycogen storage disease type IX (GSD IX) is caused by a defect in phosphorylase b kinase (PhK) that results from mutations in the PHKA2, PHKB, and PHKG2 genes. Patients usually manifest recurrent ketotic hypoglycemia with growth delay, but some may present simple hepatomegaly. Although GSD IX is one of the most common causes of GSDs, its biochemical and genetic diagnosis has been problematic due to its rarity, phenotypic overlap with other types of GSDs, and genetic heterogeneities. In our report, a 22-month-old boy with GSD IX is described. No other manifestations were evident except for hepatomegaly. His growth and development also have been proceeding normally. Diagnosed was made by histologic examination, an enzyme assay, and genetic testing with known c.3210_3212del (p.Arg1070del) mutation in PHKA2 gene.

Hepatic glycogenosis in type 1 diabetes mellitus mimicking Mauriac syndrome / 소아과

Hepatic glycogenosis in type 1 diabetes mellitus (DM) can be caused by poor glycemic control due to insulin deficiency, excessive insulin treatment for diabetic ketoacidosis, or excessive glucose administration to control hypoglycemia. Mauriac syndrome, which is characterized by hepatomegaly due to hepatic glycogenosis, growth retardation, delayed puberty, and Cushingoid features, is a rare diabetic complication. We report a case of hepatic glycogenosis mimicking Mauriac syndrome. A 14-year-old girl with poorly controlled type 1 DM was admitted to The Catholic University of Korea, Seoul St. Mary's Hospital for abdominal pain and distension. Physical examination revealed hepatomegaly and a Cushingoid face. The growth rate of the patient had decreased, and she had not yet experienced menarche. Laboratory findings revealed elevated liver enzyme levels. A liver biopsy confirmed hepatic glycogenosis. Continuous glucose monitoring showed hyperglycemia after meals and frequent hypoglycemia before meals. To control hyperglycemia, we increased insulin dosage by using an insulin pump. In addition, we prescribed uncooked cornstarch to prevent hypoglycemia. After strict blood glucose control, the patient's liver functions and size normalized. The patient subsequently underwent menarche. Hepatic glycogenosis is a complication of type 1 DM that is reversible with appropriate glycemic control.

Glicogenoses: uma revisão geral / Glycogenoses: an overeview

Compreender o metabolismo dos diferentes tipos de glicogênio no organismo humano torna-se de suma importância, pois além da sua relevância no fornecimento energético e no controle da glicemia, o glicogênio pode estar relacionado com diversos tipos de doenças que comprometem a saúde do ser humano, especialmente pela deficiência em enzimas de vias anabólicas e catabólicas. Em um contexto de avanços no desenvolvimento de pesquisas relacionadas às áreas da saúde, uma série de estudos busca entender fisiologicamente os caminhos do glicogênio em situações de exercício, repouso, jejum, dentre outras, além de analisar os mais variados transtornos decorrentes da deficiência no metabolismo desse polissacarídeo. Um exemplo são as glicogenoses, doenças hereditárias, em sua maioria de caráter recessivo, relacionadas com o armazenamento de glicogênio. Dentre alguns dos treze tipos de glicogenoses podemos citar a glicogenose tipo 0, uma doença rara que se desenvolve na infância e implica na produção defeituosa da enzima glicogênio sintase; e a glicogenose tipo I, também conhecida como Doença de Von Gierke, que se caracteriza pela deficiência no complexo enzimático glicose-6-fosfatase, responsável pela catalisação da hidrólise de glicose-6-fosfato na metabolização do glicogênio. Apesar de todas essas doenças serem caracterizadas por glicogenoses, elas possuem diferenças quanto ao órgão afetado, à gravidade de suas manifestações, o perfil etário que cada uma atinge e no efeito enzimático. Por isso, a necessidade de estudos que correlacionam as principais causas e sintomas, e visam proporcionar uma visão global dessas desordens de hereditariedade.

The comprehension of the metabolism of different types of glycogen in the human organism becomes extremely important since, other than its relevance in providing energy and controlling glycemia, glycogen can be related to many types of diseases that compromise the human health, especially when it comes to the deficiency in enzyme anabolic and catabolic pathways. In the context of advances in the development of researches related of health area, many studies inquire a physiological understanding of the glycogen pathways exercising, resting, fasting and other conditions, as well as analyzing the most varied disorders arising from hereditary deficiencies in the carbohydrate metabolism, in polysaccharide specially. The glycogenoses are hereditary disorders, which present mainly recessive feature, related with the glycogen storage. Among the thirteen types of glycogenoses, type 0 is a rare disease that develops in early stages of life and implies in the production of defective glycogen synthase enzyme; and type I is characterized by the deficiency of the glucose-6-phosphatase enzyme complex, responsible for catalyzing the hydrolysis of glucose-6- phosphate in glycogen metabolism. Although all these diseases are characterized as being glycogenoses, they possess differences as to the organ affected, the gravity of their manifestations, the age it begins to manifest, and in which way it affects enzymatic properties. Therefore, there is a necessity of studies that correlates the main causes and symptoms, and aim to provide a global vision of these hereditary disorders.

A Case of Adult Onset Glycogen Storage Myopathy / 대한임상신경생리학회지

Primary metabolic myopathy as a type of congenital myopathies was first described by McArdle in 1951. Glycogen storage disease is a disease caused by genetic mutations involved in glycogen synthesis, glycogenolysis or glycolysis. Several types of glycogen storage disease are known to cause metabolic myopathies. We report a case of adult onset metabolic myopathy with glycogen storage.

Does Type I Truly Dominate Hepatic Glycogen Storage Diseases in Korea?: A Single Center Study / 대한소아소화기영양학회지

PURPOSE: There are no studies of hepatic glycogen storage diseases (GSDs) other than type I and III in Korea. We aimed on investigating the characteristics of hepatic GSDs in Korea diagnosed and followed at a single center. METHODS: We retrospectively analyzed patients who were diagnosed as GSD and followed at Samsung Medical Center from January, 1997 to December, 2013. Clinical manifestations, laboratory results, treatment, and prognosis were investigated. RESULTS: Twenty-one patients were included in the study. The types of 17 patients were confirmed by enzyme activity tests and/or gene analysis. GSD Ia was diagnosed in 7 patients (33.3%), Ib in 1 patient (4.8%), III in 2 patients (9.5%), IV in 1 patient (4.8%), and IX in 6 patients (28.6%). Types other than GSD I constituted 52.9% (9/17) of the patients diagnosed with a specific type of hepatic GSD. The median age at presentation was 2 years. Hepatomegaly was observed in 95.2%, elevated liver transaminases in 90.5%, and hyperlactacidemia in 81.0% of the patients. The duration for follow-up was 77+/-62.0 months. Uncooked corn starch was initiated in all the patients. No mortality was observed during the follow-up period, and liver transplantation was performed in 14.3%. CONCLUSION: Types other than GSD I comprised more than half of the patients diagnosed with a specific type of hepatic GSD. Clinical suspicion and thorough evaluation of hepatic GSDs in Korea should be focused not only on GSD I, but also on other types.